Elevated IGFBP-1 cause high bone turnover in growth-restricted monochorionic twins with discordant birth weight

Bone

Volumn 38, Issue 6, 2006, Pages 929-934

  Bajoria, Rekha ^a   Sooranna, Suren R ^b   Ward, Stuart ^a   Chatterjee, Ratna ^c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Bone markers; Discordant weight; Growth factors IGFs; In utero programming; Monochorionic twins

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD SAMPLING; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS; FRAGILITY FRACTURE; GESTATIONAL AGE; GROWTH RETARDATION; HIGH RISK INFANT; HUMAN; LOW BIRTH WEIGHT; MATERNAL BLOOD; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; TWIN DISCORDANCE; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; BIRTH WEIGHT; BONE AND BONES; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; PREGNANCY; TWINS;

EID: 33749319342     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.11.003     Document Type: Article

References (35)

1. Javaid M.K., and Cooper C. Prenatal and childhood influences on osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 16 (2002) 349-367
2. Yarbrough D.E., Barrett-Connor E., and Morton D.J. Birth weight as a predictor of adult bone mass in postmenopausal women: the Rancho Bernardo Study. Osteoporos. Int. 11 (2000) 626-630
3. Godfrey K., Walker-Bone K., Robinson S., Taylor P., Shore S., Wheeler T., et al. Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J. Bone Miner. Res. 16 (2001) 1694-1703
4. Rosen C.J. Insulin-like growth factor I and bone mineral density: experience from animal models and human observational studies. Best Pract. Res. Clin. Endocrinol. Metab. 18 (2004) 423-435
5. Javaid M.K., Godfrey K.M., Taylor P., Shore S.R., Breier B., Arden N.K., et al. Umbilical venous IGF-1 concentration, neonatal bone mass, and body composition. J. Bone Miner. Res. 19 (2004) 56-63
6. Kajantie E., Hytinantti T., Koistinen R., Risteli J., Rutanen E.M., Seppala M., et al. Markers of type I and type III collagen turnover, insulin-like growth factors, and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment. Pediatr. Res. 49 (2001) 481-489
7. Eckert J.E., Gatford K.L., Luxford B.G., Campbell R.G., and Owens P.C. Leptin expression in offspring is programmed by nutrition in pregnancy. J. Endocrinol. 165 (2000) R1-R6
8. Poulter N.R., Chang C.L., MacGregor A.J., Snieder H., and Spector T.D. Association between birth weight and adult blood pressure in twins: historical cohort study. BMJ 319 7221 (1999) 1330-1333
9. Dwyer T., Blizzard L., Morley R., and Ponsonby A.L. Within pair association between birth weight and blood pressure at age 8 in twins from a cohort study. BMJ 319 7221 (1999) 1325-1329
10. Risteli L., and Risteli J. Biochemical markers of bone metabolism. Ann. Med. 25 (1993) 385-393
11. Risteli J., Elomaa I., Niemi S., Novamo A., and Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin. Chem. 39 (1993) 635-640
12. Eriksen E.F., Charles P., Melsen F., Mosekilde L., Risteli L., and Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J. Bone Miner. Res. 8 (1993) 127-132
13. Charles P., Mosekilde L., Risteli L., Risteli J., and Eriksen E.F. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner. 24 (1994) 81-94
14. Bajoria R., and Kingdom J. A case for routine determination of chorionicity and zygosity in multiple pregnancies. Prenatal. Diagn. 17 (1997) 1207-1225
15. Bajoria R., Gibson M.J., Ward S., Sooranna S.R., Neilson J.P., and Westwood M. Placental regulation of insulin-like growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome. J. Clin. Endocrinol. Metab. 86 (2001) 3150-3156
16. Petersen S., Gotfredsen A., and Knudsen F.U. Total body bone mineral in light-for-gestational-age infants and appropriate-for-gestational-age infants. Acta Paediatr. Scand. 78 (1989) 347-350
17. Namgung R., Tsang R.C., Specker B.L., Sierra R.I., and Ho M.L. Reduced serum osteocalcin and 1,25-dihydroxyvitamin D concentrations and low bone mineral content in small for gestational age infants: evidence of decreased bone formation rates. J. Pediatr. 122 (1993) 269-275
18. Namgung R., Tsang R.C., Sierra R.I., and Ho M.L. Normal serum indices of bone collagen biosynthesis and degradation in small for gestational age infants. J. Pediatr. Gastroenterol. Nutr. 23 (1996) 224-228
19. Dennison E.M., Arden N.K., Keen R.W., Syddall H., Day I.N.M., Spector T.D., et al. Birthweight vitamin D receptor genotype and the programming of osteoporosis. Paediatr. Perinat. Epidemiol. 15 (2001) 211-219
20. Bajoria R. Vascular anatomy of monochorionic placenta in relation to discordant growth and amniotic fluid volume. Hum. Reprod. 13 (1998) 2933-2940
21. Matijevic R., Ward S., and Bajoria R. Non-invasive method of evaluation of trophoblast invasion of spiral arteries in monochorionic twins with discordant birthweight. Placenta 23 (2002) 93-99
22. Bajoria R., Sooranna S.R., Ward S., D'Souza S., and Hancock M. Placental transport rather than maternal concentration of amino acids regulates fetal growth in monochorionic twins: implications for fetal origin hypothesis. Am. J. Obstet. Gynecol. 185 (2001) 1239-1246
23. Bajoria R., Sooranna S.R., Ward S., and Hancock M. Placenta as a link between amino acids, insulin-IGF axis, and low birth weight: evidence from twin studies. J. Clin. Endocrinol. Metab. 87 (2002) 308-315
24. Olney R.C., and Mougey E.B. Expression of the components of the insulin-like growth factor axis across the growth-plate. Mol. Cell Endocrinol. 156 (1999) 63-71
25. Bex M., and Bouillon R. Growth hormone and bone health. Horm. Res. 60 (2003) 80-86
26. Sims N.A., Clement-Lacroix P., Da Ponte F., et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J. Clin. Invest. 106 (2000) 1095-1103
27. Boonen S., Mohan S., Dequeker J., et al. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J. Bone Miner. Res. 14 (1999) 2150-2158
28. Westwood M. Role of insulin-like growth factor binding protein 1 in human pregnancy. Rev. Reprod. 4 (1999) 160-167
29. Smink J.J., Koster J.G., Gresnigt M.G., Rooman R., Koedam J.A., and Van Buul-Offers S.C. IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice. J Endocrinol. 175 (2002) 143-153
30. Liu J.P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75 (1993) 59-72
31. Colak O., Alatas O., Aydogdu S., and Uslu S. The effect of smoking on bone metabolism: maternal and cord blood bone marker levels. Clin. Biochem. 35 (2002) 247-250
32. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., and Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85 (1990) 632-639
33. Jackson B.T., Piasecki G.J., Cohn H.E., and Cohen W.R. Control of fetal insulin secretion. Am. J. Physiol. 279 (2000) R2179-R2188
34. Sugawara J., Tazuke S.I., Suen L.F., Powell D.R., Kaper F., Giaccia A.J., et al. Regulation of insulin-like growth factor-binding protein 1 by hypoxia and 3′,5′-cyclic adenosine monophosphate is additive in HepG2 cells. J. Clin. Endocrinol. Metab. 85 (2000) 3821-3827
35. Tazuke S.I., Mazure N.M., Sugawara J., Carland G., Faessen G.H., Suen L.F., et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 10188-10193